Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (1) Blankenstein, Thomas Prof. Dr. (23) Daniel, Peter Prof. Dr. (1) Ittermann, Bernd Dr. (1) Kammertöns, Thomas Dr. (5) Kettenmann, Helmut Prof. Dr. (2) Ku, Min-Chi Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Millward, Jason Dr. (1) Niendorf, Thoralf Prof. Dr. (27) Paul, Friedemann Prof. Dr. med. (2) Pezzutto, Antonio Prof. Dr. (2) Qadri, Fatimunnisa Dr. (1) Schulz-Menger, Jeanette Prof. Dr. (9) Uckert, Wolfgang Prof. Dr. (1) Waiczies, Helmar Dr. (8) Waiczies, Sonia PD Dr. (7) Winter, Lukas Dr. (4) Wolf, Susanne Dr. (2) (-) Kopp, Joachim Dr. (2) (-) Willimsky, Gerald Dr. (10) 1997 (1) 1998 (1) 2000 (3) (-) 2002 (1) 2005 (4) 2007 (2) 2008 (2) (-) 2010 (4) 2011 (2) 2012 (2) (-) 2013 (6) 2014 (2) 2015 (5) 2016 (5) 2017 (4) 2018 (7) 2019 (3) 2020 (4) 2021 (1) 2022 (8) 2023 (8) 2024 (1) (-) Experimental Ultrahigh-Field MR (1) Genetics of Metabolic and Reproductive Disorders (1) Magnetic Resonance (1) (-) Molecular Immunology and Gene Therapy (10) 11 Results: Active Filter: Kopp, Joachim Dr.Willimsky, Gerald Dr.Experimental Ultrahigh-Field MRMolecular Immunology and Gene Therapy200220102013 Sort: Result score Newest to oldest Oldest to newest November 01, 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel March 01, 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel March 15, 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein September 01, 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler December 16, 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein April 22, 2013 / PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf August 01, 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel March 07, 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky Pagination Current page 1 Page 2 Next page Next › Last page Last »
November 01, 2002 / Gene Ther Adenoviral transduction of tumor cells induces apoptosis in co-cultured T lymphocytes C. Scholz L. Staerck G. Willimsky T. Blankenstein B. Doerken P.T. Daniel
March 01, 2013 / J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
March 01, 2010 / Hum Gene Ther Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80/IL-2) in patients with metastatic renal cell carcinoma A. Buchner H. Pohla G. Willimsky B. Frankenberger R. Frank A. Baur-Melnyk M. Siebels C.G. Stief A. Hofstetter J. Kopp A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 15, 2010 / J Immunol In vivo imaging of an inducible oncogenic tumor antigen visualizes tumor progression and predicts CTL tolerance C. Buschow J. Charo K. Anders C. Loddenkemper A. Jukica W. Alsamah C. Perez G. Willimsky T. Blankenstein
September 01, 2010 / Eur J Immunol Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo S. Shalapour K. Deiser O. Sercan J. Tuckermann K. Minnich G. Willimsky T. Blankenstein G.J. Haemmerling B. Arnold T. Schueler
December 16, 2010 / Oncogene The immune response to sporadic colorectal cancer in a novel mouse model M. Czeh C. Loddenkemper S. Shalapour C. Schoen S. Robine E. Goldscheid H. Stein T. Schueler G. Willimsky T. Blankenstein
April 22, 2013 / PLoS ONE Design and evaluation of a hybrid radiofrequency applicator for magnetic resonance imaging and RF induced hyperthermia: electromagnetic field simulations up to 14.0 Tesla and proof-of-concept at 7.0 Tesla L. Winter C. Özerdem W. Hoffmann D. Santoro A. Müller H. Waiczies R. Seemann A. Graessl P. Wust T. Niendorf
August 01, 2013 / Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
February 08, 2013 / Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
March 07, 2013 / Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky